Bonnie H. Anderson is a veteran diagnostics industry leader with a strong track record of building successful businesses in novel markets. She has served on Veracyte’s board of directors since 2008 and was chairwoman from 2016 to 2023. Ms. Anderson cofounded Veracyte and served as the company’s Chief Executive Officer from 2008 to 2021. During her tenure as CEO of Veracyte, she spearheaded the launch of market-leading diagnostic tests that was transforming patient care in multiple disease areas and was the architect of Veracyte’s strategic vision for offering its tests to physicians and their patients globally. Prior to Veracyte, she provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter.
In addition to Veracyte, Ms. Anderson serves on the boards of Bruker Corporation, DNA Script, as a Trustee of KGI, and is President of the Coalition for 21st Century Medicine. She previously served on the boards of the Biotechnology Industry Organization (BIO) and Castle Biosciences. Ms. Anderson has received numerous awards for her industry leadership, including the Wallace H. Coulter Award for Healthcare Innovation, Fierce Pharma’s “Fiercest Women in Life Sciences,” and Fast Company’s “100 Most Creative People in Business.” Ms. Anderson graduated from Indiana University of Pennsylvania with a BS in Medical Technology and, in 2012, was honored with a “Distinguished Alumni” award.